Meaningful Use Certification Details

Size: px
Start display at page:

Download "Meaningful Use Certification Details"

Transcription

1 May 2, 2016 TRIARQ Health 1050 Wilshire, Suite 300 Troy, MI Meaningful Use Certification Details CHPL Practice Date CERTIFICATION Product Version Classification PRODUCT Type Certified EDITION NUMBER glosuite 8.0 Ambulatory Complete EHR 1/22/ R00 glosuite 8.1 Ambulatory Complete EHR 1/22/ R01 glosuite 8.2 Ambulatory Complete EHR 9/30/ R00 glosuite 8.3 Ambulatory Complete EHR 12/23/ R01 glosuite 8.4 Ambulatory Complete EHR 4/30/ R02 glosuite 8.5 Ambulatory Complete EHR 4/30/ R03 TRIARQ Health is pleased to announce that glosuite 8 is 2014 ONC Certified compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services. Vendor: TRIARQ Health (formerly glostream) Date Certified: January 22, 2014 Product Name and Version: glosuite 8 Unique Certification Number: R00 Certification Criteria (41) (a)(1) COMPUTERIZED PROVIDER ORDER ENTRY (a)(2) DRUG-DRUG, DRUG-ALLERGY INTERACTION CHECKS (a)(3) DEMOGRAPHICS (a)(4) VITAL SIGNS, BODY MASS INDEX, AND GROWTH CHARTS (a)(5) PROBLEM LIST (a)(6) MEDICATION LIST (a)(7) MEDICATION ALLERGY LIST (a)(8) CLINICAL DECISION SUPPORT

2 (a)(9) ELECTRONIC NOTES (a)(10) DRUG-FORMULARY CHECKS (a)(11) SMOKING STATUS (a)(12) IMAGE RESULTS (a)(13) FAMILY HEALTH HISTORY (a)(14) PATIENT LIST CREATION (a)(15) PATIENT-SPECIFIC EDUCATION RESOURCES (b)(1) TRANSITIONS OF CARE - RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES (b)(2) TRANSITIONS OF CARE - CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES (b)(3) ELECTRONIC PRESCRIBING (b)(4) CLINICAL INFORMATION RECONCILIATION (b)(5) INCORPORATE LABORATORY TESTS AND VALUES/RESULTS (b)(7) DATA PORTABILITY (c)(1) CLINICAL QUALITY MEASURES - CAPTURE AND EXPORT (c)(2) CLINICAL QUALITY MEASURES - IMPORT AND CALCULATE (c)(3) CLINICAL QUALITY MEASURES - ELECTRONIC SUBMISSION (d)(1) AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION (d)(2) AUDITABLE EVENTS AND TAMPER-RESISTANCE (d)(3) AUDIT REPORT(S) (d)(4) AMENDMENTS (d)(5) AUTOMATIC LOG-OFF (d)(6) EMERGENCY ACCESS (d)(7) END-USER DEVICE ENCRYPTION (d)(8) INTEGRITY (e)(1) VIEW, DOWNLOAD, AND TRANSMIT TO 3RD PARTY (e)(2) CLINICAL SUMMARY (e)(3) SECURE MESSAGING (f)(1) IMMUNIZATION INFORMATION (f)(2) TRANSMISSION TO IMMUNIZATION REGISTRIES (f)(3) TRANSMISSION TO PUBLIC HEALTH AGENCIES - SYNDROMIC SURVEILLANCE (g)(2) AUTOMATED MEASURE CALCULATION (g)(3) SAFETY-ENHANCED DESIGN (g)(4) QUALITY MANAGEMENT SYSTEM Clinical Quality Measures (14) CMS68 DOCUMENTATION OF CURRENT MEDICATIONS IN THE MEDICAL RECORD

3 CMS90 FUNCTIONAL STATUS ASSESSMENT FOR COMPLEX CHRONIC CONDITIONS CMS122 DIABETES: HEMOGLOBIN A1C POOR CONTROL CMS123 DIABETES: FOOT EXAM CMS127 PNEUMONIA VACCINATION STATUS FOR OLDER ADULTS CMS131 DIABETES: EYE EXAM CMS134 DIABETES: URINE PROTEIN SCREENING CMS138 PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING AND CESSATION INTERVENTION CMS146 APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS CMS147 PREVENTATIVE CARE AND SCREENING: INFLUENZA IMMUNIZATION CMS163 DIABETES: LOW DENSITY LIPOPROTEIN (LDL) MANAGEMENT CMS164 ISCHEMIC VASCULAR DISEASE (IVD): USE OF ASPIRIN OR ANOTHER ANTITHROMBOTIC CMS165 CONTROLLING HIGH BLOOD PRESSURE CMS166 USE OF IMAGING STUDIES FOR LOW BACK PAIN Additional for Demonstration Name of Additional Associated Criteria Specify Functionality Provided Microsoft Word (a)(9) Electronic notes Document electronic notes Dragon Naturally Speaking Medispan Drugs Database HL7- UltraPort MSSQL Schema Engine (a)(9) Electronic notes provider order entry - Medication Orders (a)(2) Drug-drug, drugallergy interaction checks (a)(7) Medication allergy list provider order entry- Labs & Radiology Orders, (b)(5)(A) Incorporate (f)(2) Transmission to Immunization Registries Dictation in electronic notes Record Patient Medication, Check drug to drug interaction, Document Medication allergy list Electronic Labs and order entry, Electronic Labs interface, Transmit to Immunization Registries, Transmit to Syndromic Surveillance Registry

4 (f)(3) Transmission to public health agencies - syndromic surveillance SQL Server All Data Repository & Reporting Meinberg NTP (d)(2) Auditable events and tamper-resistance Time Synchronization Service Surescripts Emdeon (b)(3) Electronic prescribing (b)(1) Transitions of care receive, display and incorporate transition of care referral summaries (b)(2) Transitions of care create and transmit transition of care referral summaries (b)(5)(A) Incorporate erx, Rx Eligibility & Direct Messaging Electronic Labs interface TRIARQ Health is pleased to announce that glosuite 8.1 is 2014 ONC Certified compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services. Vendor: TRIARQ Health (formerly glostream) Date Certified: January 22, 2014 Product Name and Version: glosuite 8.1 Unique Certification Number: R01 Certification Criteria (41) (a)(1) COMPUTERIZED PROVIDER ORDER ENTRY (a)(2) DRUG-DRUG, DRUG-ALLERGY INTERACTION CHECKS (a)(3) DEMOGRAPHICS

5 (a)(4) VITAL SIGNS, BODY MASS INDEX, AND GROWTH CHARTS (a)(5) PROBLEM LIST (a)(6) MEDICATION LIST (a)(7) MEDICATION ALLERGY LIST (a)(8) CLINICAL DECISION SUPPORT (a)(9) ELECTRONIC NOTES (a)(10) DRUG-FORMULARY CHECKS (a)(11) SMOKING STATUS (a)(12) IMAGE RESULTS (a)(13) FAMILY HEALTH HISTORY (a)(14) PATIENT LIST CREATION (a)(15) PATIENT-SPECIFIC EDUCATION RESOURCES (b)(1) TRANSITIONS OF CARE - RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES (b)(2) TRANSITIONS OF CARE - CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES (b)(3) ELECTRONIC PRESCRIBING (b)(4) CLINICAL INFORMATION RECONCILIATION (b)(5) INCORPORATE LABORATORY TESTS AND VALUES/RESULTS (b)(7) DATA PORTABILITY (c)(1) CLINICAL QUALITY MEASURES - CAPTURE AND EXPORT (c)(2) CLINICAL QUALITY MEASURES - IMPORT AND CALCULATE (c)(3) CLINICAL QUALITY MEASURES - ELECTRONIC SUBMISSION (d)(1) AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION (d)(2) AUDITABLE EVENTS AND TAMPER-RESISTANCE (d)(3) AUDIT REPORT(S) (d)(4) AMENDMENTS (d)(5) AUTOMATIC LOG-OFF (d)(6) EMERGENCY ACCESS (d)(7) END-USER DEVICE ENCRYPTION (d)(8) INTEGRITY (e)(1) VIEW, DOWNLOAD, AND TRANSMIT TO 3RD PARTY (e)(2) CLINICAL SUMMARY (e)(3) SECURE MESSAGING (f)(1) IMMUNIZATION INFORMATION (f)(2) TRANSMISSION TO IMMUNIZATION REGISTRIES (f)(3) TRANSMISSION TO PUBLIC HEALTH AGENCIES - SYNDROMIC SURVEILLANCE (g)(2) AUTOMATED MEASURE CALCULATION

6 (g)(3) SAFETY-ENHANCED DESIGN (g)(4) QUALITY MANAGEMENT SYSTEM Clinical Quality Measures (14) CMS68 DOCUMENTATION OF CURRENT MEDICATIONS IN THE MEDICAL RECORD CMS90 FUNCTIONAL STATUS ASSESSMENT FOR COMPLEX CHRONIC CONDITIONS CMS122 DIABETES: HEMOGLOBIN A1C POOR CONTROL CMS123 DIABETES: FOOT EXAM CMS127 PNEUMONIA VACCINATION STATUS FOR OLDER ADULTS CMS131 DIABETES: EYE EXAM CMS134 DIABETES: URINE PROTEIN SCREENING CMS138 PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING AND CESSATION INTERVENTION CMS146 APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS CMS147 PREVENTATIVE CARE AND SCREENING: INFLUENZA IMMUNIZATION CMS163 DIABETES: LOW DENSITY LIPOPROTEIN (LDL) MANAGEMENT CMS164 ISCHEMIC VASCULAR DISEASE (IVD): USE OF ASPIRIN OR ANOTHER ANTITHROMBOTIC CMS165 CONTROLLING HIGH BLOOD PRESSURE CMS166 USE OF IMAGING STUDIES FOR LOW BACK PAIN Additional for Demonstration Name of Additional Associated Criteria Specify Functionality Provided Microsoft Word (a)(9) Electronic notes Document electronic notes Dragon Naturally Speaking Medispan Drugs Database HL7- UltraPort MSSQL Schema Engine (a)(9) Electronic notes provider order entry - Medication Orders (a)(2) Drug-drug, drugallergy interaction checks (a)(7) Medication allergy list provider order entry- Labs & Radiology Orders, Dictation in electronic notes Record Patient Medication, Check drug to drug interaction, Document Medication allergy list Electronic Labs and order entry, Electronic Labs interface, Transmit to Immunization

7 (b)(5)(A) Incorporate (f)(2) Transmission to Immunization Registries (f)(3) Transmission to public health agencies - syndromic surveillance Registries, Transmit to Syndromic Surveillance Registry SQL Server All Data Repository & Reporting Meinberg NTP (d)(2) Auditable events and tamper-resistance Time Synchronization Service Surescripts Emdeon (b)(3) Electronic prescribing (b)(1) Transitions of care receive, display and incorporate transition of care referral summaries (b)(2) Transitions of care create and transmit transition of care referral summaries (b)(5)(A) Incorporate erx, Rx Eligibility & Direct Messaging Electronic Labs interface TRIARQ Health is pleased to announce that glosuite 8.2 is 2014 ONC Certified compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services. Vendor: TRIARQ Health (formerly glostream) Date Certified: September 30, 2014 Product Name and Version: glosuite 8.2 Unique Certification Number: R00

8 Certification Criteria (41) (a)(1) COMPUTERIZED PROVIDER ORDER ENTRY (a)(2) DRUG-DRUG, DRUG-ALLERGY INTERACTION CHECKS (a)(3) DEMOGRAPHICS (a)(4) VITAL SIGNS, BODY MASS INDEX, AND GROWTH CHARTS (a)(5) PROBLEM LIST (a)(6) MEDICATION LIST (a)(7) MEDICATION ALLERGY LIST (a)(8) CLINICAL DECISION SUPPORT (a)(9) ELECTRONIC NOTES (a)(10) DRUG-FORMULARY CHECKS (a)(11) SMOKING STATUS (a)(12) IMAGE RESULTS (a)(13) FAMILY HEALTH HISTORY (a)(14) PATIENT LIST CREATION (a)(15) PATIENT-SPECIFIC EDUCATION RESOURCES (b)(1) TRANSITIONS OF CARE - RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES (b)(2) TRANSITIONS OF CARE - CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES (b)(3) ELECTRONIC PRESCRIBING (b)(4) CLINICAL INFORMATION RECONCILIATION (b)(5) INCORPORATE LABORATORY TESTS AND VALUES/RESULTS (b)(7) DATA PORTABILITY (c)(1) CLINICAL QUALITY MEASURES - CAPTURE AND EXPORT (c)(2) CLINICAL QUALITY MEASURES - IMPORT AND CALCULATE (c)(3) CLINICAL QUALITY MEASURES - ELECTRONIC SUBMISSION (d)(1) AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION (d)(2) AUDITABLE EVENTS AND TAMPER-RESISTANCE (d)(3) AUDIT REPORT(S) (d)(4) AMENDMENTS (d)(5) AUTOMATIC LOG-OFF (d)(6) EMERGENCY ACCESS (d)(7) END-USER DEVICE ENCRYPTION (d)(8) INTEGRITY (e)(1) VIEW, DOWNLOAD, AND TRANSMIT TO 3RD PARTY

9 (e)(2) CLINICAL SUMMARY (e)(3) SECURE MESSAGING (f)(1) IMMUNIZATION INFORMATION (f)(2) TRANSMISSION TO IMMUNIZATION REGISTRIES (f)(3) TRANSMISSION TO PUBLIC HEALTH AGENCIES - SYNDROMIC SURVEILLANCE (g)(2) AUTOMATED MEASURE CALCULATION (g)(3) SAFETY-ENHANCED DESIGN (g)(4) QUALITY MANAGEMENT SYSTEM Clinical Quality Measures (14) CMS68 DOCUMENTATION OF CURRENT MEDICATIONS IN THE MEDICAL RECORD CMS90 FUNCTIONAL STATUS ASSESSMENT FOR COMPLEX CHRONIC CONDITIONS CMS122 DIABETES: HEMOGLOBIN A1C POOR CONTROL CMS123 DIABETES: FOOT EXAM CMS127 PNEUMONIA VACCINATION STATUS FOR OLDER ADULTS CMS131 DIABETES: EYE EXAM CMS134 DIABETES: URINE PROTEIN SCREENING CMS138 PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING AND CESSATION INTERVENTION CMS146 APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS CMS147 PREVENTATIVE CARE AND SCREENING: INFLUENZA IMMUNIZATION CMS163 DIABETES: LOW DENSITY LIPOPROTEIN (LDL) MANAGEMENT CMS164 ISCHEMIC VASCULAR DISEASE (IVD): USE OF ASPIRIN OR ANOTHER ANTITHROMBOTIC CMS165 CONTROLLING HIGH BLOOD PRESSURE CMS166 USE OF IMAGING STUDIES FOR LOW BACK PAIN Additional for Demonstration Name of Additional Associated Criteria Specify Functionality Provided Microsoft Word (a)(9) Electronic notes Document electronic notes Dragon Naturally Speaking Medispan Drugs Database (a)(9) Electronic notes provider order entry - Medication Orders (a)(2) Drug-drug, drugallergy interaction checks Dictation in electronic notes Record Patient Medication, Check drug to drug interaction, Document Medication allergy list

10 HL7- UltraPort MSSQL Schema Engine (a)(7) Medication allergy list provider order entry- Labs & Radiology Orders, (b)(5)(A) Incorporate (f)(2) Transmission to Immunization Registries Electronic Labs and order entry, Electronic Labs interface, Transmit to Immunization Registries, Transmit to Syndromic Surveillance Registry (f)(3) Transmission to public health agencies - syndromic surveillance SQL Server All Data Repository & Reporting Meinberg NTP NTPD (d)(2) Auditable events and tamper-resistance NTPD is used as Time Synchronization Service for Medfusion Portal Surescripts Emdeon Medfusion Patient Portal (optional) (b)(3) Electronic prescribing (b)(1) Transitions of care receive, display and incorporate transition of care referral summaries (b)(2) Transitions of care create and transmit transition of care referral summaries (b)(5)(A) Incorporate (e)(3) Secure Messaging (e)(1) View, Download, and Transmit to 3rd Party erx, Rx Eligibility & Direct Messaging Electronic Labs interface Send Secure Messages View download and Transmit

11 (g)(2) Automated Measure Calculation for e3 and e1 TRIARQ Health is pleased to announce that glosuite 8.3 is 2014 ONC Certified compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services. Vendor: TRIARQ Health (formerly glostream) Date Certified: December 23, 2014 Product Name and Version: glosuite 8.3 Unique Certification Number: R01 Certification Criteria (41) (a)(1) COMPUTERIZED PROVIDER ORDER ENTRY (a)(2) DRUG-DRUG, DRUG-ALLERGY INTERACTION CHECKS (a)(3) DEMOGRAPHICS (a)(4) VITAL SIGNS, BODY MASS INDEX, AND GROWTH CHARTS (a)(5) PROBLEM LIST (a)(6) MEDICATION LIST (a)(7) MEDICATION ALLERGY LIST (a)(8) CLINICAL DECISION SUPPORT (a)(9) ELECTRONIC NOTES (a)(10) DRUG-FORMULARY CHECKS (a)(11) SMOKING STATUS (a)(12) IMAGE RESULTS (a)(13) FAMILY HEALTH HISTORY (a)(14) PATIENT LIST CREATION (a)(15) PATIENT-SPECIFIC EDUCATION RESOURCES (b)(1) TRANSITIONS OF CARE - RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES (b)(2) TRANSITIONS OF CARE - CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES (b)(3) ELECTRONIC PRESCRIBING (b)(4) CLINICAL INFORMATION RECONCILIATION

12 (b)(5) INCORPORATE LABORATORY TESTS AND VALUES/RESULTS (b)(7) DATA PORTABILITY (c)(1) CLINICAL QUALITY MEASURES - CAPTURE AND EXPORT (c)(2) CLINICAL QUALITY MEASURES - IMPORT AND CALCULATE (c)(3) CLINICAL QUALITY MEASURES - ELECTRONIC SUBMISSION (d)(1) AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION (d)(2) AUDITABLE EVENTS AND TAMPER-RESISTANCE (d)(3) AUDIT REPORT(S) (d)(4) AMENDMENTS (d)(5) AUTOMATIC LOG-OFF (d)(6) EMERGENCY ACCESS (d)(7) END-USER DEVICE ENCRYPTION (d)(8) INTEGRITY (e)(1) VIEW, DOWNLOAD, AND TRANSMIT TO 3RD PARTY (e)(2) CLINICAL SUMMARY (e)(3) SECURE MESSAGING (f)(1) IMMUNIZATION INFORMATION (f)(2) TRANSMISSION TO IMMUNIZATION REGISTRIES (f)(3) TRANSMISSION TO PUBLIC HEALTH AGENCIES - SYNDROMIC SURVEILLANCE (g)(2) AUTOMATED MEASURE CALCULATION (g)(3) SAFETY-ENHANCED DESIGN (g)(4) QUALITY MANAGEMENT SYSTEM Clinical Quality Measures (14) CMS68 DOCUMENTATION OF CURRENT MEDICATIONS IN THE MEDICAL RECORD CMS90 FUNCTIONAL STATUS ASSESSMENT FOR COMPLEX CHRONIC CONDITIONS CMS122 DIABETES: HEMOGLOBIN A1C POOR CONTROL CMS123 DIABETES: FOOT EXAM CMS127 PNEUMONIA VACCINATION STATUS FOR OLDER ADULTS CMS131 DIABETES: EYE EXAM CMS134 DIABETES: URINE PROTEIN SCREENING CMS138 PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING AND CESSATION INTERVENTION CMS146 APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS CMS147 PREVENTATIVE CARE AND SCREENING: INFLUENZA IMMUNIZATION CMS163 DIABETES: LOW DENSITY LIPOPROTEIN (LDL) MANAGEMENT CMS164 ISCHEMIC VASCULAR DISEASE (IVD): USE OF ASPIRIN OR ANOTHER ANTITHROMBOTIC

13 CMS165 CONTROLLING HIGH BLOOD PRESSURE CMS166 USE OF IMAGING STUDIES FOR LOW BACK PAIN Additional for Demonstration Name of Additional Associated Criteria Specify Functionality Provided Microsoft Word (a)(9) Electronic notes Document electronic notes Dragon Naturally Speaking Medispan Drugs Database HL7- UltraPort MSSQL Schema Engine (a)(9) Electronic notes provider order entry - Medication Orders (a)(2) Drug-drug, drugallergy interaction checks (a)(7) Medication allergy list provider order entry- Labs & Radiology Orders, (b)(5)(A) Incorporate (f)(2) Transmission to Immunization Registries Dictation in electronic notes Record Patient Medication, Check drug to drug interaction, Document Medication allergy list Electronic Labs and order entry, Electronic Labs interface, Transmit to Immunization Registries, Transmit to Syndromic Surveillance Registry (f)(3) Transmission to public health agencies - syndromic surveillance SQL Server All Data Repository & Reporting Meinberg NTP NTPD (d)(2) Auditable events and tamper-resistance NTPD is used as Time Synchronization Service for Medfusion Portal Surescripts (b)(3) Electronic prescribing erx, Rx Eligibility & Direct Messaging

14 Emdeon Medfusion Patient Portal (optional) (b)(1) Transitions of care receive, display and incorporate transition of care referral summaries (b)(2) Transitions of care create and transmit transition of care referral summaries (b)(5)(A) Incorporate (e)(3) Secure Messaging (e)(1) View, Download, and Transmit to 3rd Party (g)(2) Automated Measure Calculation for e3 and e1 Electronic Labs interface Send Secure Messages View download and Transmit TRIARQ Health is pleased to announce that glosuite 8.4 is 2014 ONC Certified compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services. Vendor: TRIARQ Health (formerly glostream) Date Certified: April 30, 2014 Product Name and Version: glosuite 8.4 Unique Certification Number: R02 Certification Criteria (41) (a)(1) COMPUTERIZED PROVIDER ORDER ENTRY (a)(2) DRUG-DRUG, DRUG-ALLERGY INTERACTION CHECKS (a)(3) DEMOGRAPHICS (a)(4) VITAL SIGNS, BODY MASS INDEX, AND GROWTH CHARTS (a)(5) PROBLEM LIST

15 (a)(6) MEDICATION LIST (a)(7) MEDICATION ALLERGY LIST (a)(8) CLINICAL DECISION SUPPORT (a)(9) ELECTRONIC NOTES (a)(10) DRUG-FORMULARY CHECKS (a)(11) SMOKING STATUS (a)(12) IMAGE RESULTS (a)(13) FAMILY HEALTH HISTORY (a)(14) PATIENT LIST CREATION (a)(15) PATIENT-SPECIFIC EDUCATION RESOURCES (b)(1) TRANSITIONS OF CARE - RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES (b)(2) TRANSITIONS OF CARE - CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES (b)(3) ELECTRONIC PRESCRIBING (b)(4) CLINICAL INFORMATION RECONCILIATION (b)(5) INCORPORATE LABORATORY TESTS AND VALUES/RESULTS (b)(7) DATA PORTABILITY (c)(1) CLINICAL QUALITY MEASURES - CAPTURE AND EXPORT (c)(2) CLINICAL QUALITY MEASURES - IMPORT AND CALCULATE (c)(3) CLINICAL QUALITY MEASURES - ELECTRONIC SUBMISSION (d)(1) AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION (d)(2) AUDITABLE EVENTS AND TAMPER-RESISTANCE (d)(3) AUDIT REPORT(S) (d)(4) AMENDMENTS (d)(5) AUTOMATIC LOG-OFF (d)(6) EMERGENCY ACCESS (d)(7) END-USER DEVICE ENCRYPTION (d)(8) INTEGRITY (e)(1) VIEW, DOWNLOAD, AND TRANSMIT TO 3RD PARTY (e)(2) CLINICAL SUMMARY (e)(3) SECURE MESSAGING (f)(1) IMMUNIZATION INFORMATION (f)(2) TRANSMISSION TO IMMUNIZATION REGISTRIES (f)(3) TRANSMISSION TO PUBLIC HEALTH AGENCIES - SYNDROMIC SURVEILLANCE (g)(2) AUTOMATED MEASURE CALCULATION (g)(3) SAFETY-ENHANCED DESIGN (g)(4) QUALITY MANAGEMENT SYSTEM

16 Clinical Quality Measures (14) CMS68 DOCUMENTATION OF CURRENT MEDICATIONS IN THE MEDICAL RECORD CMS90 FUNCTIONAL STATUS ASSESSMENT FOR COMPLEX CHRONIC CONDITIONS CMS122 DIABETES: HEMOGLOBIN A1C POOR CONTROL CMS123 DIABETES: FOOT EXAM CMS127 PNEUMONIA VACCINATION STATUS FOR OLDER ADULTS CMS131 DIABETES: EYE EXAM CMS134 DIABETES: URINE PROTEIN SCREENING CMS138 PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING AND CESSATION INTERVENTION CMS146 APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS CMS147 PREVENTATIVE CARE AND SCREENING: INFLUENZA IMMUNIZATION CMS163 DIABETES: LOW DENSITY LIPOPROTEIN (LDL) MANAGEMENT CMS164 ISCHEMIC VASCULAR DISEASE (IVD): USE OF ASPIRIN OR ANOTHER ANTITHROMBOTIC CMS165 CONTROLLING HIGH BLOOD PRESSURE CMS166 USE OF IMAGING STUDIES FOR LOW BACK PAIN Additional for Demonstration Name of Additional Associated Criteria Specify Functionality Provided Microsoft Word (a)(9) Electronic notes Document electronic notes Dragon Naturally Speaking Medispan Drugs Database HL7- UltraPort MSSQL Schema Engine (a)(9) Electronic notes provider order entry - Medication Orders (a)(2) Drug-drug, drugallergy interaction checks (a)(7) Medication allergy list provider order entry- Labs & Radiology Orders, (b)(5)(A) Incorporate Dictation in electronic notes Record Patient Medication, Check drug to drug interaction, Document Medication allergy list Electronic Labs and order entry, Electronic Labs interface, Transmit to Immunization Registries, Transmit to Syndromic Surveillance Registry

17 (f)(2) Transmission to Immunization Registries (f)(3) Transmission to public health agencies - syndromic surveillance SQL Server All Data Repository & Reporting Meinberg NTP NTPD (d)(2) Auditable events and tamper-resistance NTPD is used as Time Synchronization Service for Medfusion Portal Surescripts Emdeon Medfusion Patient Portal (optional) (b)(3) Electronic prescribing (b)(1) Transitions of care receive, display and incorporate transition of care referral summaries (b)(2) Transitions of care create and transmit transition of care referral summaries (b)(5)(A) Incorporate (e)(3) Secure Messaging (e)(1) View, Download, and Transmit to 3rd Party (g)(2) Automated Measure Calculation for e3 and e1 erx, Rx Eligibility & Direct Messaging Electronic Labs interface Send Secure Messages View download and Transmit TRIARQ Health is pleased to announce that glosuite 8.5 is 2014 ONC Certified compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

18 Vendor: TRIARQ Health (formerly glostream) Date Certified: April 30, 2014 Product Name and Version: glosuite 8.5 Unique Certification Number: R03 Certification Criteria (41) (a)(1) COMPUTERIZED PROVIDER ORDER ENTRY (a)(2) DRUG-DRUG, DRUG-ALLERGY INTERACTION CHECKS (a)(3) DEMOGRAPHICS (a)(4) VITAL SIGNS, BODY MASS INDEX, AND GROWTH CHARTS (a)(5) PROBLEM LIST (a)(6) MEDICATION LIST (a)(7) MEDICATION ALLERGY LIST (a)(8) CLINICAL DECISION SUPPORT (a)(9) ELECTRONIC NOTES (a)(10) DRUG-FORMULARY CHECKS (a)(11) SMOKING STATUS (a)(12) IMAGE RESULTS (a)(13) FAMILY HEALTH HISTORY (a)(14) PATIENT LIST CREATION (a)(15) PATIENT-SPECIFIC EDUCATION RESOURCES (b)(1) TRANSITIONS OF CARE - RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES (b)(2) TRANSITIONS OF CARE - CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES (b)(3) ELECTRONIC PRESCRIBING (b)(4) CLINICAL INFORMATION RECONCILIATION (b)(5) INCORPORATE LABORATORY TESTS AND VALUES/RESULTS (b)(7) DATA PORTABILITY (c)(1) CLINICAL QUALITY MEASURES - CAPTURE AND EXPORT (c)(2) CLINICAL QUALITY MEASURES - IMPORT AND CALCULATE (c)(3) CLINICAL QUALITY MEASURES - ELECTRONIC SUBMISSION (d)(1) AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION (d)(2) AUDITABLE EVENTS AND TAMPER-RESISTANCE (d)(3) AUDIT REPORT(S) (d)(4) AMENDMENTS (d)(5) AUTOMATIC LOG-OFF

19 (d)(6) EMERGENCY ACCESS (d)(7) END-USER DEVICE ENCRYPTION (d)(8) INTEGRITY (e)(1) VIEW, DOWNLOAD, AND TRANSMIT TO 3RD PARTY (e)(2) CLINICAL SUMMARY (e)(3) SECURE MESSAGING (f)(1) IMMUNIZATION INFORMATION (f)(2) TRANSMISSION TO IMMUNIZATION REGISTRIES (f)(3) TRANSMISSION TO PUBLIC HEALTH AGENCIES - SYNDROMIC SURVEILLANCE (g)(2) AUTOMATED MEASURE CALCULATION (g)(3) SAFETY-ENHANCED DESIGN (g)(4) QUALITY MANAGEMENT SYSTEM Clinical Quality Measures (14) CMS68 DOCUMENTATION OF CURRENT MEDICATIONS IN THE MEDICAL RECORD CMS90 FUNCTIONAL STATUS ASSESSMENT FOR COMPLEX CHRONIC CONDITIONS CMS122 DIABETES: HEMOGLOBIN A1C POOR CONTROL CMS123 DIABETES: FOOT EXAM CMS127 PNEUMONIA VACCINATION STATUS FOR OLDER ADULTS CMS131 DIABETES: EYE EXAM CMS134 DIABETES: URINE PROTEIN SCREENING CMS138 PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING AND CESSATION INTERVENTION CMS146 APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS CMS147 PREVENTATIVE CARE AND SCREENING: INFLUENZA IMMUNIZATION CMS163 DIABETES: LOW DENSITY LIPOPROTEIN (LDL) MANAGEMENT CMS164 ISCHEMIC VASCULAR DISEASE (IVD): USE OF ASPIRIN OR ANOTHER ANTITHROMBOTIC CMS165 CONTROLLING HIGH BLOOD PRESSURE CMS166 USE OF IMAGING STUDIES FOR LOW BACK PAIN Additional for Demonstration Name of Additional Associated Criteria Specify Functionality Provided Microsoft Word (a)(9) Electronic notes Document electronic notes Dragon Naturally Speaking (a)(9) Electronic notes Dictation in electronic notes

20 Medispan Drugs Database HL7- UltraPort MSSQL Schema Engine provider order entry - Medication Orders (a)(2) Drug-drug, drugallergy interaction checks (a)(7) Medication allergy list provider order entry- Labs & Radiology Orders, (b)(5)(A) Incorporate (f)(2) Transmission to Immunization Registries (f)(3) Transmission to public health agencies - syndromic surveillance Record Patient Medication, Check drug to drug interaction, Document Medication allergy list Electronic Labs and order entry, Electronic Labs interface, Transmit to Immunization Registries, Transmit to Syndromic Surveillance Registry SQL Server All Data Repository & Reporting Meinberg NTP NTPD (d)(2) Auditable events and tamper-resistance NTPD is used as Time Synchronization Service for Medfusion Portal Surescripts (b)(3) Electronic prescribing (b)(1) Transitions of care receive, display and incorporate transition of care referral summaries (b)(2) Transitions of care create and transmit transition of care referral summaries erx, Rx Eligibility & Direct Messaging

21 Emdeon Medfusion Patient Portal (optional) (b)(5)(A) Incorporate (e)(3) Secure Messaging (e)(1) View, Download, and Transmit to 3rd Party (g)(2) Automated Measure Calculation for e3 and e1 Electronic Labs interface Send Secure Messages View download and Transmit Additional Info/Limitations: As part of acquiring the 2014 ONC Certified gloemr, gloemr, there are several separate pieces that must be purchased and maintained by the EP s practice organization: a. gloemr application one-time cost and monthly fee per provider OR glocomplete package [Revenue Cycle Management] with monthly fee as percent of practice revenue; b. glopatientportal patient-facing web portal - upfront cost and monthly per provider fee OR Medfusion Patient Portal -patient-facing web portal -upfront cost and monthly provider fee; c. glodirect DIRECT messaging function upfront cost and monthly per provider fee; d. Immunization Registry Interface upfront cost and monthly per provider fee. If Needed: a. Syndromic Surveillance Registry Interface one-time cost and monthly per provider fee; b. Specialized Registry Interface one-time cost and monthly per provider fee. Special: a. Lab Interface not required but can enhance practice performance - one-time cost and monthly per provider fee; b. Emdeon Lab Interface not required but recommended, can enhance practice performance - one-time cost and monthly per provider fee. New versions of glosuite will be available to all current glosuite customers as a no-charge update. glosuite is a package offering consisting of EHR, and gloportal, and is available to new customers either through a one-time license fee, to include implementation service fees, and ongoing annual maintenance and support, or in a hosted model with an upfront implementation fee and ongoing

22 monthly hosted service fees. Incremental costs that an eligible provider would pay to implement glosuite in order to meet meaningful use objectives and measures may include: One-time costs to establish interfaces for outgoing lab orders, inbound lab, HIEs, registries, and public health agencies ( b.5, f.1, f.2, f.3) Ongoing costs either on a per transaction or per provider per month basis for electronic prescribing, outgoing lab orders, and inbound lab ( a.2, a.10, b.3, b.5) Ongoing monthly costs to support online patient portal, secure direct messaging, and interfaces for HIEs, registries, and public health agencies ( b.1, b.2, e.1, e.3, f.1, f.2, f.2, f.3) This language will be displayed on TRIARQ Health s website here: TRIARQ Health further agrees to notify ICSA Labs of any and all future changes to TRIARQ Health s transparency and disclosures language for this certified product-version. TRIARQ Health understands and agrees that the ONC HIT Certification Program Final Rule statement gives ICSA Labs, as an ONC-ACB, the sole responsibility for ensuring compliance and determining appropriate consequences if EHR technology developers fail to disclose accurate transparency and disclosures information. TRIARQ Health further agrees that it will provide to ICSA Labs copies of or give access to any and all websites, marketing materials, communication statements and other assertions made by TRIARQ Health regarding the ONC certification status of this product within a reasonable time to ensure the transparency and disclosures information is accurately disclosed. For further questions, please contact Julie Lundberg at

Meaningful Use Measures: Quick Reference Guide Stage 2 (2014 and Beyond)

Meaningful Use Measures: Quick Reference Guide Stage 2 (2014 and Beyond) Meaningful Use Measures: Quick Reference Guide Stage 2 (2014 and Beyond) Core Measures Required: All 17 objectives Objective: Requirement: Exclusions: Accomplish in Clinical 1. Computerized - Documenting

More information

MEANINGFUL USE STAGE 2

MEANINGFUL USE STAGE 2 MEANINGFUL USE STAGE 2 PHASED-IN IMPLEMENTATION PROCESS DECEMBER 2014 - PREPARATION MONTH Start this process as early as possible WATCH VIDEO TRAINING SESSIONS: (Sessions available starting December 1,

More information

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 2

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 2 Meaningful Use Hello Health v7 Guide for Eligible Professionals Stage 2 Table of Contents Introduction 3 Meaningful Use 3 Terminology 4 Computerized Provider Order Entry (CPOE) for Medication, Laboratory

More information

Stage 2 Meaningful Use Objectives and Measures

Stage 2 Meaningful Use Objectives and Measures Stage 2 Meaningful Use Objectives and Measures Author: Mia Evans About Technosoft Solutions: Technosoft Solutions is a healthcare technology consulting, dedicated to providing software development services

More information

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 1

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 1 Meaningful Use Hello Health v7 Guide for Eligible Professionals Stage 1 Table of Contents Introduction 3 Meaningful Use 3 Terminology 5 Computerized Provider Order Entry (CPOE) for Medication Orders [Core]

More information

Computer Provider Order Entry (CPOE)

Computer Provider Order Entry (CPOE) Computer Provider Order Entry (CPOE) Use computerized provider order entry (CPOE) for medication orders directly entered by any licensed healthcare professional who can enter orders into the medical record

More information

STAGE 2 PROPOSED REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1

STAGE 2 PROPOSED REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1 STAGE 2 PROPOSED REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1 Requirement CPOE Use CPOE for medication orders directly entered by any licensed health care professional who can enter orders into the

More information

Appendix 4 CMS Stage 1 Meaningful Use Requirements Summary Tables 4-1 APPENDIX 4 CMS STAGE 1 MEANINGFUL USE REQUIREMENTS SUMMARY

Appendix 4 CMS Stage 1 Meaningful Use Requirements Summary Tables 4-1 APPENDIX 4 CMS STAGE 1 MEANINGFUL USE REQUIREMENTS SUMMARY Appendix 4 CMS Stage 1 Meaningful Use Requirements Summary Tables 4-1 APPENDIX 4 CMS STAGE 1 MEANINGFUL USE REQUIREMENTS SUMMARY 1. Use CPOE (computerized physician order entry) for medication orders directly

More information

REQUIREMENTS GUIDE: How to Qualify for EHR Stimulus Funds under ARRA

REQUIREMENTS GUIDE: How to Qualify for EHR Stimulus Funds under ARRA REQUIREMENTS GUIDE: How to Qualify for EHR Stimulus Funds under ARRA Meaningful Use & Certified EHR Technology The American Recovery and Reinvestment Act (ARRA) set aside nearly $20 billion in incentive

More information

2015 MEANINGFUL USE STAGE 2 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

2015 MEANINGFUL USE STAGE 2 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY 2015 MEANINGFUL USE STAGE 2 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY STAGE 2 REQUIREMENTS EPs must meet or qualify for an exclusion to 17 core objectives EPs must meet 3 of the 6 menu measures.

More information

Stage 2 Meaningful Use: Menu Objectives and Clinical Quality Measures. James R. Christina, DPM Director Scientific Affairs APMA

Stage 2 Meaningful Use: Menu Objectives and Clinical Quality Measures. James R. Christina, DPM Director Scientific Affairs APMA Stage 2 Meaningful Use: Menu Objectives and Clinical Quality Measures James R. Christina, DPM Director Scientific Affairs APMA What Stage Am I In? 2 2 CMS Proposed Rule On May 20, 2014 CMS and Office of

More information

GE Healthcare. Meaningful Use 2014 Prep: Core Part 1. Ramsey Antoun, Training Operations Coordinator December 12, 2013

GE Healthcare. Meaningful Use 2014 Prep: Core Part 1. Ramsey Antoun, Training Operations Coordinator December 12, 2013 GE Healthcare Meaningful Use 2014 Prep: Core Part 1 Ramsey Antoun, Training Operations Coordinator December 12, 2013 2013 General Electric Company All rights reserved. This does not constitute a representation

More information

Meaningful Use: a Primer

Meaningful Use: a Primer Health Information Technology Extension Center of Los Angeles Meaningful Use: a Primer Mary Mitchell Director of Meaningful Use Defined as: What is Meaningful Use? A. Use of a certified EHR in a meaningful

More information

Relevance of Meaningful Use Requirements for Pathologists and Laboratories Pathology Informatics 2011 October 5, 2011

Relevance of Meaningful Use Requirements for Pathologists and Laboratories Pathology Informatics 2011 October 5, 2011 Relevance of Meaningful Use Requirements for Pathologists and Laboratories Pathology Informatics 2011 October 5, 2011 Walter H. Henricks, M.D. Cleveland Clinic Meaningful Use and the Laboratory Outline

More information

Beyond Meaningful Use: Driving Improved Quality. CHCANYS Webinar #1: December 14, 2016

Beyond Meaningful Use: Driving Improved Quality. CHCANYS Webinar #1: December 14, 2016 Beyond Meaningful Use: Driving Improved Quality CHCANYS Webinar #1: December 14, 2016 Agenda The Current State Measuring Monitoring & Reporting Quality. Meaningful Use 2018 and Beyond The New Quality Payment

More information

Meaningful Use Stages 1 & 2

Meaningful Use Stages 1 & 2 Meaningful Use Stages 1 & 2 Making Sure You Get the Most Out of Your EHR Tracy McDonald Medicaid EHR Incentive Program Coordinator Agenda Meaningful Use Stages & Incentive Program Timing 2014 Changes to

More information

Iatric Systems Supports the Achievement of Meaningful Use

Iatric Systems Supports the Achievement of Meaningful Use Iatric Systems Supports the Achievement of Meaningful Use Iatric Systems offers a wide variety of solutions to assist with today s business challenges and support hospitals in providing superior patient

More information

Final Meaningful Use Objectives for

Final Meaningful Use Objectives for Final Meaningful Use Objectives All Eligible Professionals (EP) must attest to all objectives using a 2014 Edition CEHRT. Stage 2 Objective Protect Health Information Clinical Decision Support Stage 2

More information

Meaningful Use Stage 1 Guide for 2013

Meaningful Use Stage 1 Guide for 2013 Meaningful Use Stage 1 Guide for 2013 Aprima PRM 2011 December 20, 2013 2013 Aprima Medical Software. All rights reserved. Aprima is a registered trademark of Aprima Medical Software. All other trademarks

More information

Medicare & Medicaid. William Kassler, MD Chief Medical Officer Centers for Medicare & Medicaid Services Boston, MA

Medicare & Medicaid. William Kassler, MD Chief Medical Officer Centers for Medicare & Medicaid Services Boston, MA Medicare & Medicaid EHR Incentive Program William Kassler, MD Chief Medical Officer Centers for Medicare & Medicaid Services Boston, MA Overview Background / Policy Context EHR Incentive Program basics

More information

ASCs and Meaningful Use. Patrick Doyle, Vice President Sales Jessica McBrayer, RN, Business Analyst Ron Pelletier, Vice President Market Strategy

ASCs and Meaningful Use. Patrick Doyle, Vice President Sales Jessica McBrayer, RN, Business Analyst Ron Pelletier, Vice President Market Strategy ASCs and Meaningful Use Patrick Doyle, Vice President Sales Jessica McBrayer, RN, Business Analyst Ron Pelletier, Vice President Market Strategy Today s Discussion Review of Meaningful Use and implications

More information

Final Meaningful Use Objectives for

Final Meaningful Use Objectives for Final Meaningful Use Objectives Modified Stage 2 All Eligible Professionals (EP) must attest to all objectives using a 2014 Edition CEHRT. Stage 2 Objective Protect Health Information Clinical Decision

More information

during the EHR reporting period.

during the EHR reporting period. CMS Stage 2 MU Proposed Objectives and Measures for EPs Objective Measure Notes and Queries PUT YOUR COMMENTS HERE CORE SET (EP must meet all 17 Core Set objectives) Exclusion: Any EP who writes fewer

More information

ecw and NextGen MEETING MU REQUIREMENTS

ecw and NextGen MEETING MU REQUIREMENTS ecw and NextGen MEETING MU REQUIREMENTS ecw version 9.0 is Meaningful Use certified and will be upgraded in Munson hosted practices. Anticipated to be released the end of February. NextGen application

More information

Provide an understanding of what comprises "meaningful use" of EHR technology

Provide an understanding of what comprises meaningful use of EHR technology 1 Provide background on federal electronic health record (EHR) incentives Overview of Health IT Incentives Medicare/Medicaid EHR incentives Provide an understanding of what comprises "meaningful use" of

More information

Meaningful Use Participation Basics for the Small Provider

Meaningful Use Participation Basics for the Small Provider Meaningful Use Participation Basics for the Small Provider Vidya Sellappan Centers for Medicare & Medicaid Services Office of E-Health Standards and Services HIT Initiatives Group July 30, 2014 EHR INCENTIVE

More information

Meaningful Use Modified Stage 2 Roadmap Eligible Hospitals

Meaningful Use Modified Stage 2 Roadmap Eligible Hospitals Evident is dedicated to making your transition to Meaningful Use as seamless as possible. In an effort to assist our customers with implementation of the software conducive to meeting Meaningful Use requirements,

More information

Final Meaningful Use Objectives for 2017

Final Meaningful Use Objectives for 2017 Final Meaningful Use Objectives Modified Stage 2 All Eligible Professionals (EP) must attest to all objectives using a 2014 Edition or a combination of 2014 & 2015 CEHRT. Stage 2 Objective Protect Health

More information

MEANINGFUL USE STAGE FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

MEANINGFUL USE STAGE FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY MEANINGFUL USE STAGE 2 2014 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY STAGE 2 REQUIREMENTS EPs must meet or qualify for an exclusion to 17 core objectives. EPs must meet 3 of the 6 menu measures.

More information

Stage 1 Changes Tipsheet Last Updated: August, 2012

Stage 1 Changes Tipsheet Last Updated: August, 2012 Stage 1 Changes Tipsheet Last Updated: August, 2012 Overview CMS recently announced some changes to the Stage 1 meaningful use objectives, measures, and exclusions for eligible professionals (EPs), eligible

More information

2011 Measures 2013 Objectives Goal is to guide and support care processes and care coordination

2011 Measures 2013 Objectives Goal is to guide and support care processes and care coordination Improve quality, safety, efficiency, and reduce health disparities Provide access to comprehensive patient health data for patient s health care team Use evidencebased order sets and CPOE Apply clinical

More information

of 23 Meaningful Use 2015 PER THE CMS REVISION TO THE FINAL RULE RELEASED OCTOBER 6, 2015 CHARTMAKER MEDICAL SUITE

of 23 Meaningful Use 2015 PER THE CMS REVISION TO THE FINAL RULE RELEASED OCTOBER 6, 2015 CHARTMAKER MEDICAL SUITE 1 Meaningful Use 2015 PER THE CMS REVISION TO THE FINAL RULE RELEASED OCTOBER 6, 2015 CHARTMAKER MEDICAL SUITE WHEN WE ARE FINISHED TODAY YOU SHOULD KNOW THE FOLLOWING. 2 EHR reporting periods Amended

More information

Meaningful Use Stage 2

Meaningful Use Stage 2 Meaningful Use Stage 2 Presented by: Deb Anderson, HTS Consultant HTS, a division of Mountain Pacific Quality Health Foundation 1 HTS Who We Are Stage 2 MU Overview Learning Objectives 2014 CEHRT Certification

More information

Meaningful Use May, 2012

Meaningful Use May, 2012 Meaningful Use May, 2012 Shehnaz Scheyer New Jersey Institute of Technology 211 Warren Street, Newark, NJ 07103 Phone: 973-557-4571 x716 Fax: 973-846-4634 Email: sscheyer@csicorp.net www.njhitec.org Eligible

More information

Abstract. Are eligible providers participating? AdvancedMD EHR features streamline meaningful use processes: Complete & accurate information

Abstract. Are eligible providers participating? AdvancedMD EHR features streamline meaningful use processes: Complete & accurate information Abstract As part of the American Recovery and Reinvestment Act of 2009, the Federal Government laid the groundwork for the nationwide implementation of electronic health records (EHR) systems as a measure

More information

Meaningful Use Reporting period for 2017: Change: Any consecutive 90 days in 2017 for Medicaid customers only.

Meaningful Use Reporting period for 2017: Change: Any consecutive 90 days in 2017 for Medicaid customers only. Meaningful Use 2017 Reporting period for 2017: Change: Any consecutive 90 days in 2017 for Medicaid customers only. Who needs to report on Meaningful Use for 2017? Medicaid customers who have 30 % Medicaid

More information

Meaningful Use - Modified Stage 2. Brett Paepke, OD David Wolfson Marni Anderson

Meaningful Use - Modified Stage 2. Brett Paepke, OD David Wolfson Marni Anderson Meaningful Use - Modified Stage 2 Brett Paepke, OD David Wolfson Marni Anderson Wait! Where did Stage 1 and Stage 2 go? Traditional stages eliminated in late 2015 in order to: 1. reduce reporting requirements

More information

Medicare & Medicaid EHR Incentive Program Final Rule. Implementing the American Recovery & Reinvestment Act of 2009

Medicare & Medicaid EHR Incentive Program Final Rule. Implementing the American Recovery & Reinvestment Act of 2009 Medicare & Medicaid EHR Incentive Program Final Rule Implementing the American Recovery & Reinvestment Act of 2009 Conceptual Approach to Meaningful Use Improved Data capture and sharing Advanced Clinical

More information

American Recovery & Reinvestment Act

American Recovery & Reinvestment Act American Recovery & Reinvestment Act Meaningful Use Dawn Ross, Clinical Informatics Director Linda Wilson, Meaningful Use Coordinator 10/26/2015 Overview American Recovery and Reinvestment Act of 2009

More information

MEANINGFUL USE TRAINING SCENARIOS GUIDE

MEANINGFUL USE TRAINING SCENARIOS GUIDE MEANINGFUL USE TRAINING SCENARIOS GUIDE A guide to the most common scenarios in becoming a Meaningful User with eclinicalworks Version 9.0. eclinicalworks, Rev D, April 2011. All rights reserved Contents

More information

Qualifying for Medicare Incentive Payments with Crystal Practice Management. Version 1.0

Qualifying for Medicare Incentive Payments with Crystal Practice Management. Version 1.0 Qualifying for Medicare Incentive Payments with Crystal Practice Management Version 1.0 July 18, Table of Contents Qualifying for Medicare Incentive Payments with... 1 General Information... 3 Links to

More information

Meaningful Use and PCC EHR. Tim Proctor Users Conference 2017

Meaningful Use and PCC EHR. Tim Proctor Users Conference 2017 Meaningful Use and PCC EHR Tim Proctor (tim@pcc.com) Users Conference 2017 Agenda MU basics and eligibility How to participate in MU What s Next for MU? Meeting MU measures in PCC EHR Takeaways An understanding

More information

PROPOSED MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

PROPOSED MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY PROPOSED MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY On February 23, the Centers for Medicare & Medicaid Services (CMS) posted the much anticipated proposed

More information

Stage 1 Meaningful Use Objectives and Measures

Stage 1 Meaningful Use Objectives and Measures Stage 1 Meaningful Use Objectives and Measures Author: Mia Evans About Technosoft Solutions: Technosoft Solutions is a healthcare technology consulting, dedicated to providing software development services

More information

MEANINGFUL USE 2015 PROPOSED 2015 MEANINGFUL USE FLEXIBILITY RULE

MEANINGFUL USE 2015 PROPOSED 2015 MEANINGFUL USE FLEXIBILITY RULE MEANINGFUL USE 2015 PROPOSED 2015 MEANINGFUL USE FLEXIBILITY RULE *Please note, the below guidelines are currently proposed. ASCRS will let you know if and when they are finalized through regulatory alerts

More information

Ophthalmology Meaningful Use Attestation Guide 2016 Edition Updated July 2016

Ophthalmology Meaningful Use Attestation Guide 2016 Edition Updated July 2016 Ophthalmology Meaningful Use Attestation Guide 2016 Edition Updated July 2016 Provided by the American Academy of Ophthalmology and the American Academy of Ophthalmic Executives (AAOE), the Academy's practice

More information

THE MEANING OF MEANINGFUL USE CHANGES IN THE STAGE 2 MU FINAL RULE. Angel L. Moore, MAEd, RHIA Eastern AHEC REC

THE MEANING OF MEANINGFUL USE CHANGES IN THE STAGE 2 MU FINAL RULE. Angel L. Moore, MAEd, RHIA Eastern AHEC REC THE MEANING OF MEANINGFUL USE CHANGES IN THE STAGE 2 MU FINAL RULE Angel L. Moore, MAEd, RHIA Eastern AHEC REC WE WILL BRIEFLY DISCUSS Meaningful Use (MU) Incentive Programs, Eligibility & Timelines WE

More information

Medicare and Medicaid EHR Incentive Program. Stage 3 and Modifications to Meaningful Use in 2015 through 2017 Final Rule with Comment

Medicare and Medicaid EHR Incentive Program. Stage 3 and Modifications to Meaningful Use in 2015 through 2017 Final Rule with Comment Medicare and Medicaid EHR Incentive Program Stage 3 and Modifications to Meaningful Use in 2015 through 2017 Final Rule with Comment Measures, and Proposed Alternative Measures with Select Proposed 1 Protect

More information

HITECH Act American Recovery and Reinvestment Act (ARRA) Stimulus Package. HITECH Act Meaningful Use (MU)

HITECH Act American Recovery and Reinvestment Act (ARRA) Stimulus Package. HITECH Act Meaningful Use (MU) Presents Presents: Speaker: Elizabeth Woodcock, MBA, FACMPE, CPC www.elizabethwoodcock.com Speaker: Elizabeth Woodcock, MBA, FACMPE, CPC www.elizabethwoodcock.com HITECH Act Meaningful Use (MU) Definition

More information

Medicare & Medicaid EHR Incentive Programs. Stage 2 Final Rule Travis Broome AMIA

Medicare & Medicaid EHR Incentive Programs. Stage 2 Final Rule Travis Broome AMIA Medicare & Medicaid EHR Incentive Programs Stage 2 Final Rule Travis Broome AMIA 9-20-2012 What is in the Rule Changes to Stage 1 of meaningful use Stage 2 of meaningful use New clinical quality measures

More information

The History of Meaningful Use

The History of Meaningful Use A Guide to Modified Meaningful Use Stage 2 for Wound Care Practitioners for 2015 The History of Meaningful Use During the first term of the Obama administration in 2009, Congress passed the Health Information

More information

Meaningful Use Stage 2 For Eligible and Critical Access Hospitals

Meaningful Use Stage 2 For Eligible and Critical Access Hospitals Meaningful Use Stage 2 For Eligible and Critical Access Hospitals Eileen Colen This material was prepared by HealthInsight, the Medicare Quality Improvement Organization for Nevada and Utah, under contract

More information

PBSI-EHR Off the Charts Meaningful Use in 2016 The Patient Engagement Stage

PBSI-EHR Off the Charts Meaningful Use in 2016 The Patient Engagement Stage PBSI-EHR Off the Charts Meaningful Use in 2016 The Patient Engagement Stage Please note that this document is intended to supplement the information available on the CMS website for Meaningful Use for

More information

in partnership with EHR Meaningful Use Guide for HITECH Attestation

in partnership with EHR Meaningful Use Guide for HITECH Attestation in partnership with EHR Meaningful Use Guide for HITECH Attestation Getting Started This guide will help ensure that you meet or exceed the core and menu objectives required for HITECH Meaningful Use.

More information

Meaningful Use: Review of Changes to Objectives and Measures in Final Rule

Meaningful Use: Review of Changes to Objectives and Measures in Final Rule Meaningful Use: Review of Changes to Objectives and Measures in Final Rule The proposed rule on meaningful use established 27 objectives that participants would meet in stage 1 of the program. The final

More information

HIE Implications in Meaningful Use Stage 1 Requirements

HIE Implications in Meaningful Use Stage 1 Requirements s in Meaningful Use Stage 1 Requirements HIMSS Health Information Exchange Steering Committee March 2010 2010 Healthcare Information and Management Systems Society (HIMSS). 1 An HIE Overview Health Information

More information

CHIME Concordance Analysis of Stage 2 Meaningful Use Final Rule - Objectives & Measures

CHIME Concordance Analysis of Stage 2 Meaningful Use Final Rule - Objectives & Measures CHIME Concordance Analysis of Stage 2 Meaningful Use Final Rule - Objectives & Measures Stage 2 MU Objectives and Measures for EHs - Core More than 60 percent of medication, 1. Use CPOE for medication,

More information

EHR Incentive Programs for Eligible Professionals: What You Need to Know for 2016 Tipsheet

EHR Incentive Programs for Eligible Professionals: What You Need to Know for 2016 Tipsheet EHR Incentive Programs for Eligible Professionals: What You Need to Know for 2016 Tipsheet CMS published a final rule that specifies criteria that eligible professionals (EPs), eligible hospitals, and

More information

The results will also be used for public reporting for MN Community Measurement on mnhealthscores.org.

The results will also be used for public reporting for MN Community Measurement on mnhealthscores.org. Introduction Welcome to the Health Information Technology (HIT) Ambulatory Clinic Survey. The Minnesota Department of Health (MDH) established the Minnesota Statewide Quality Reporting and Measurement

More information

Stage 2 Eligible Professional Meaningful Use Core and Menu Measures. User Manual/Guide for Attestation using encompass 3.0

Stage 2 Eligible Professional Meaningful Use Core and Menu Measures. User Manual/Guide for Attestation using encompass 3.0 Stage 2 Eligible Professional Meaningful Use Core and Menu Measures User Manual/Guide for Attestation using encompass 3.0 Prepared By: Arête Healthcare Services, LLC Document Version: V1.0 9/02/2015 Eligible

More information

Eligible Professionals (EP) Meaningful Use Final Objectives and Measures for Stage 1, 2011

Eligible Professionals (EP) Meaningful Use Final Objectives and Measures for Stage 1, 2011 Eligible Professionals (EP) Meaningful Use Final Objectives and Measures for Stage 1, 2011 1 On demand webinars are best heard through a headset or earphones (ipod for example) that can be plugged into

More information

EHR Meaningful Use Guide

EHR Meaningful Use Guide EHR Meaningful Use Guide for Stage I (2011) HITECH Attestation Version 2.0 Updated May/June 2014 in partnership with 1-866-611-5428 herfert@medicfusion.com www.medicfusion.com/herfert Medicfusion EMR V1.1

More information

ACO GPRO 2016 Ready to Report Basics GPRO ACO Random Sample Reporting January 17, 2017 to March 17, 2017

ACO GPRO 2016 Ready to Report Basics GPRO ACO Random Sample Reporting January 17, 2017 to March 17, 2017 ACO GPRO 2016 Ready to Report Basics 2016 GPRO ACO Random Sample Reporting January 17, 2017 to March 17, 2017 ACO GPRO 2016 Ready to Report Basics What is an Accountable Care Organization (ACO)? Which

More information

Meaningful Use Final Rule:

Meaningful Use Final Rule: Meaningful Use Final Rule: Safety and Quality of Care Jonathan Teich, FACMI, FHIMSS, MD, PhD CMIO, Elsevier Health Sciences August 4, 2010 Today s webinar is sponsored by History HITECH Feb. 2009 Initial

More information

HITECH* Update Meaningful Use Regulations Eligible Professionals

HITECH* Update Meaningful Use Regulations Eligible Professionals HITECH* Update Meaningful Use Regulations Eligible Professionals October 2010 * Health Information Technology for Economic and Clinical Health, a component of the ARRA of 2009 McDowell Lecture December

More information

The HITECH EHR "Meaningful Use" Requirements for Hospitals and Eligible Professionals

The HITECH EHR Meaningful Use Requirements for Hospitals and Eligible Professionals The HITECH EHR "Meaningful Use" Requirements for Hospitals and Eligible Professionals The HITECH EHR "Meaningful Use" Requirements for Hospitals and Eligible Professionals September 1, 2010 Presented and

More information

EHR/Meaningful Use

EHR/Meaningful Use EHR/Meaningful Use 2015-2017 The requirements for Meaningful Use attestation have changed due to the recently released Medicare and Medicaid Programs: Electronic Health Record Incentive Program Stage 3

More information

Achieving Meaningful Use with Centricity Electronic Medical Record

Achieving Meaningful Use with Centricity Electronic Medical Record GE Healthcare Achieving Meaningful Use with Centricity Electronic Medical Record Version 9.8 Revised July 2015 Centricity EMR DOC1620430 2015 General Electric Company All information is subject to change

More information

Webinar #5 Meaningful Use: Looking Ahead to Stage 2 and CPS 12

Webinar #5 Meaningful Use: Looking Ahead to Stage 2 and CPS 12 New York State-Health Centered Controlled Network (NYS HCCN) Webinar #5 Meaningful Use: Looking Ahead to Stage 2 and CPS 12 December 10, 2013 Ekem Merchant-Bleiberg, Director of Implementation Services

More information

Harnessing the Power of MHS Information Systems to Achieve Meaningful Use of Health Information

Harnessing the Power of MHS Information Systems to Achieve Meaningful Use of Health Information 2011 Military Health System Conference Harnessing the Power of MHS Information Systems to Achieve Meaningful Use of Health Information The Quadruple Aim: Working Together, Achieving Success Forum Moderator:

More information

Texas Medicaid Electronic Health Record (EHR) Incentive Program: Federally Qualified Health Centers (FQHCs)

Texas Medicaid Electronic Health Record (EHR) Incentive Program: Federally Qualified Health Centers (FQHCs) Texas Medicaid Electronic Health Record (EHR) Incentive Program: Federally Qualified Health Centers (FQHCs) Julia Alejandre, Medicaid / CHIP Health IT Jason Phipps, Medicaid / CHIP Health IT July 20, 2012

More information

Clinical LOINC Meeting - Salt Lake City, UT USA. Updates on LOINC. Daniel J. Vreeman, PT, DPT, MSc

Clinical LOINC Meeting - Salt Lake City, UT USA. Updates on LOINC. Daniel J. Vreeman, PT, DPT, MSc Clinical LOINC Meeting - Salt Lake City, UT USA Updates on LOINC Daniel J. Vreeman, PT, DPT, MSc Associate Research Professor, Indiana University School of Medicine Associate Director for Terminology Services,

More information

2018 Modified Stage 3 Meaningful Use Criteria for Eligible Professionals (EPs)*

2018 Modified Stage 3 Meaningful Use Criteria for Eligible Professionals (EPs)* 2018 Modified Stage 3 Meaningful Use Criteria for Eligible Professionals (EPs)* n In order for an EP to be considered a meaningful electronic health record (EHR) user, at least 50 percent of the EP s patient

More information

Meaningful Use Basics and Attestation Process Guide for Medicare and Medi-Cal. Lori Hack & Val Tuerk, Object Health

Meaningful Use Basics and Attestation Process Guide for Medicare and Medi-Cal. Lori Hack & Val Tuerk, Object Health Meaningful Use Basics and Attestation Process Guide for Medicare and Medi-Cal Lori Hack & Val Tuerk, Object Health 2 3 Agenda Who Qualifies for the EHR Incentive Funds? EHR Incentive Registration Process

More information

FINAL Meaningful Use Objectives for

FINAL Meaningful Use Objectives for Meaningful Use s All Eligible Professionals (EP) and Eligible Hospitals (EH) must attest to all objectives using a 2014 Edition CEHRT. Protect Electronic Health Information Protect electronic health information

More information

Security Risk Analysis and 365 Days of Meaningful Use. Rodney Gauna & Val Tuerk, Object Health

Security Risk Analysis and 365 Days of Meaningful Use. Rodney Gauna & Val Tuerk, Object Health Security Risk Analysis and 365 Days of Meaningful Use Rodney Gauna & Val Tuerk, Object Health 2 3 Agenda Guidelines for Conducting a Security Risk Analysis Scope of Analysis Risk of a Breach Security Risks

More information

Meaningful Use Stage 2

Meaningful Use Stage 2 Meaningful Use Stage 2 Objectives Gain understanding of the changes Focus on Transitions in Care and Patient Engagement Recognize the increasing HIE role Who Are You? What is YOUR Need Today? A. Office

More information

A complete step by step guide on how to achieve Meaningful Use Core Set Measures in Medgen EHR.

A complete step by step guide on how to achieve Meaningful Use Core Set Measures in Medgen EHR. Medgen EHR A complete step by step guide on how to achieve Meaningful Use Core Set Measures in Medgen EHR. Contents Important information regarding Meaningful Use... 2 How to generate your measure report

More information

Measures Reporting for Eligible Providers

Measures Reporting for Eligible Providers Meaningful Use White Paper Series Paper no. 5a: Measures Reporting for Eligible Providers Published September 4, 2010 Measures Reporting for Eligible Providers The fourth paper in this series reviewed

More information

Roll Out of the HIT Meaningful Use Standards and Certification Criteria

Roll Out of the HIT Meaningful Use Standards and Certification Criteria Roll Out of the HIT Meaningful Use Standards and Certification Criteria Chuck Ingoglia, Vice President, Public Policy National Council for Community Behavioral Healthcare February 19, 2010 Purpose of Today

More information

EHR Incentives. Profit by using LOGO a certified EHR. EHR vs. EMR. PQRI Incentives. Incentives available

EHR Incentives. Profit by using LOGO a certified EHR. EHR vs. EMR. PQRI Incentives. Incentives available EHR vs. EMR EHR Incentives Company Profit by using LOGO a certified EHR EMR - Electronic records of health-related information on an individual that can be created, gathered, managed, and consulted by

More information

APPENDIX 2 NCQA PCMH 2011 AND CMS STAGE 1 MEANINGFUL USE REQUIREMENTS

APPENDIX 2 NCQA PCMH 2011 AND CMS STAGE 1 MEANINGFUL USE REQUIREMENTS Appendix 2 NCQA PCMH 2011 and CMS Stage 1 Meaningful Use Requirements 2-1 APPENDIX 2 NCQA PCMH 2011 AND CMS STAGE 1 MEANINGFUL USE REQUIREMENTS CMS Meaningful Use Requirements* All Providers Must Meet

More information

Benchmark Data Sources

Benchmark Data Sources Medicare Shared Savings Program Quality Measure Benchmarks for the 2016 and 2017 Reporting Years Introduction This document describes methods for calculating the quality performance benchmarks for Accountable

More information

Agenda 2. EHR Incentive Programs 3/5/2015. Overview EHR incentive programs Meaningful Use Differences between Stage 1 and Stage 2

Agenda 2. EHR Incentive Programs 3/5/2015. Overview EHR incentive programs Meaningful Use Differences between Stage 1 and Stage 2 Meaningful Use and the Electronic Health Record Presented by: Susan Reehill CPC, CEMC, CHONC, CPMA Certified Professional Medical Auditor AHIMA Approved ICD-10 CM/PCS Trainer Overview EHR incentive programs

More information

CHCANYS NYS HCCN ecw Webinar

CHCANYS NYS HCCN ecw Webinar CHCANYS NYS HCCN ecw Webinar Meaningful Use, V10 and UDS January 30, 2013 Stephanie Rose, Project Director Desiree Railine, HIT Implementation Specialist/Trainer Agenda Meaningful Use Stage 1 2014 Review

More information

Improving Quality of Care for Medicare Patients: Accountable Care Organizations

Improving Quality of Care for Medicare Patients: Accountable Care Organizations DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services Improving Quality of Care for Medicare Patients: FACT SHEET Overview http://www.cms.gov/sharedsavingsprogram On October

More information

MEANINGFUL USE BASICS

MEANINGFUL USE BASICS MEANINGFUL USE BASICS Medicare $44,000 Medicaid $63,000 What is Meaningful Use? Meaningful Use is an umbrella term for rules and regulations that health care providers can meet to qualify for federal incentive

More information

Meaningful Use Roadmap

Meaningful Use Roadmap Meaningful Use Roadmap Copyright SOAPware, Inc. 2011 1 Introduction 1.1 2 3 Introduction 6 Registration and Attestation 2.1 1. Request the "CMS EHR Certification ID" for SOAPware 9 2.2 2. Register for

More information

Medicaid Provider Incentive Program

Medicaid Provider Incentive Program Medicaid Provider Incentive Program The Road to Meaningful Use Ohio Association of Community Health Centers 2013 Spring Conference March 6, 2013 Presenters: Elbony McIntyre, Project Manager Emma Esmont,

More information

Meaningful Use and PCC EHR

Meaningful Use and PCC EHR Meaningful Use and PCC EHR (tim@pcc.com) Users Conference 2016 Agenda MU basics and eligibility How to participate in MU Meeting MU measures in PCC EHR Understanding CQM reporting in PCC EHR Takeaways

More information

Medicare & Medicaid EHR Incentive Program Final Rule. Implementing the American Recovery & Reinvestment Act of 2009

Medicare & Medicaid EHR Incentive Program Final Rule. Implementing the American Recovery & Reinvestment Act of 2009 Medicare & Medicaid EHR Incentive Program Final Rule Implementing the American Recovery & Reinvestment Act of 2009 Purpose of this Presentation To give an overview of the CMS final rule on the EHR Incentive

More information

United Medical ACO Participation Criteria

United Medical ACO Participation Criteria United Medical ACO Participation Criteria Items Requiring Practice Reporting 1) Submission of Reports: Practices must report A,B, and C to UMACO A. Thirty-four ACO Quality Measures -See Appendix A B. Average

More information

Accelerating the Impact of Performance Measures: Role of Core Measures

Accelerating the Impact of Performance Measures: Role of Core Measures Accelerating the Impact of Performance Measures: Role of Core Measures Mark McClellan, MD, PhD Director, Engelberg Center for Health Care Reform Senior Fellow, Economic Studies Leonard D. Schaeffer Chair

More information

Quality Measurement and Reporting Kickoff

Quality Measurement and Reporting Kickoff Quality Measurement and Reporting Kickoff All Shared Savings Program ACOs April 11, 2017 Sandra Adams, RN; Rabia Khan, MPH Division of Shared Savings Program Medicare Shared Savings Program DISCLAIMER

More information

Measures Reporting for Eligible Hospitals

Measures Reporting for Eligible Hospitals Meaningful Use White Paper Series Paper no. 5b: Measures Reporting for Eligible Hospitals Published September 5, 2010 Measures Reporting for Eligible Hospitals The fourth paper in this series reviewed

More information

Stage 1. Meaningful Use 2014 Edition User Manual

Stage 1. Meaningful Use 2014 Edition User Manual Stage 1 Meaningful Use 2014 Edition User Manual This document, as well as the software described in it, is provided under a software license agreement with STI Computer Services, Inc. Use of this software

More information

CMS EHR Incentive Programs Overview

CMS EHR Incentive Programs Overview CMS EHR Incentive Programs Overview Elizabeth Holland and Robert Anthony Session 20, Room 320 Monday, February 24 at 11:30 AM DISCLAIMER: The views and opinions expressed in this presentation are those

More information

Understanding Your Meaningful Use Report

Understanding Your Meaningful Use Report Understanding Your Meaningful Use Report Distributed by Kowa Optimed EMRlogic activehr Understanding Your Meaningful Use Report, version 2.1 Publication Date: May 8, 2012 OD Professional and activehr OD

More information

EHR Incentive Programs: 2015 through 2017 (Modified Stage 2) Overview

EHR Incentive Programs: 2015 through 2017 (Modified Stage 2) Overview EHR Incentive Programs: 2015 through (Modified Stage 2) Overview CMS recently released a final rule that specifies criteria that eligible professionals (EPs), eligible hospitals, and critical access hospitals

More information

HIE Implications in Meaningful Use Stage 1 Requirements

HIE Implications in Meaningful Use Stage 1 Requirements HIE Implications in Meaningful Use Stage 1 Requirements HIMSS 2010-2011 Health Information Exchange Committee November 2010 The inclusion of an organization name, product or service in this publication

More information